Nikotinamid-/Nikotinsäuremononukleotid-Adenylyltransferase 1

Keen TJ et al. (2003) Identification of a locus (LCA9) for Leber's congenital amaurosis on chromosome 1p36.

Zhai RG et al. (2006) Drosophila NMNAT maintains neural integrity independent of its NAD synthesis activity.

Falk MJ et al. (2012) NMNAT1 mutations cause Leber congenital amaurosis.

Perrault I et al. (2012) Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy.

Koenekoop RK et al. (2012) Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration.

Emanuelli M et al. (2001) Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase.

Schweiger M et al. (2001) Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis.

Zhou T et al. (2002) Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin.

Fernando FS et al. (2002) Human homologue of a gene mutated in the slow Wallerian degeneration (C57BL/Wld(s)) mouse.

Zhang X et al. (2003) Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis.

Araki T et al. (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration.

MacDonald JM et al. (2006) The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons.

Zhai RG et al. (2008) NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration.

Orphanet article

NCBI article

OMIM.ORG article